Value of consecutive galactomannan determinations for the diagnosis and prognosis of invasive pulmonary aspergillosis in critically ill chronic obstructive pulmonary disease

Management of invasive aspergillosis in patients with COPD: rational use of voriconazole

(2012) Florence Ader   International Journal of Chronic Obstructive Pulmonary Disease

Invasive pulmonary aspergillosis in acute exacerbation of chronic obstructive pulmonary disease and the diagnostic value of combined serological tests

(2010) Xiaofang Gao et al.   ANNALS OF SAUDI MEDICINE

Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients

(2009) Johan Maertens et al.   CANCER

Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome

(2009) J. Guinea et al.   CLINICAL MICROBIOLOGY AND INFECTION

Aspergillosis

(2009) Brahm H. Segal   NEW ENGLAND JOURNAL OF MEDICINE

Assessment of Aspergillus fumigatus Burden in Pulmonary Tissue of Guinea Pigs by Quantitative PCR, Galactomannan Enzyme Immunoassay, and Quantitative Culture

(2008) A. C. Vallor et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Value of a single galactomannan determination (Platelia) for the diagnosis of invasive aspergillosis in non-hematological patients with clinical isolation ofAspergillusspp.

(2008) Jesús Guinea et al.   MEDICAL MYCOLOGY

Conventional or molecular measurement ofAspergillusload

(2008) K. V. Clemons et al.   MEDICAL MYCOLOGY

Invasive pulmonary aspergillosis in patients with COPD: a report of five cases and systematic review of the literature

(2008) P. Samarakoon et al.   Chronic Respiratory Disease